Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Ugo Consoli"'
Autor:
Vittorio Del Fabro, Uros Markovic, Sara Frazzetto, Roberta Sciortino, Claudia Bellofiore, Mary Ann Di Giorgio, Valerio Leotta, Anna Bulla, Angelo Curto Pelle, Federica Elia, Donato Mannina, Ugo Consoli, Giuseppe Mineo, Cesarina Giallongo, Alessandra Romano, Francesco Di Raimondo, Concetta Conticello
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
BackgroundWaldenström macroglobulinemia (WM) is a rare and indolent B-cell lymphoproliferative disorder with greater incidence in elderly patients where a precise algorithm of initial therapy is still not clear. Immunochemotherapy regimen consisting
Externí odkaz:
https://doaj.org/article/dec050af6ec34f2ea4f3548e908d35e3
Publikováno v:
Case Reports in Hematology, Vol 2023 (2023)
Immune thrombocytopenia (ITP) is immune-mediated platelet loss due to increased destruction and insufficient production. Treatment guidelines provide for first-line steroid-based therapies followed by thrombopoietin receptor agonists (TPO-RAs) and fo
Externí odkaz:
https://doaj.org/article/d34b41b5bad74b2a84119de8fb143d78
Autor:
Mario Petrini, Gianluca Gaidano, Andrea Mengarelli, Ugo Consoli, Armando Santoro, Anna Maria Liberati, Marco Ladetto, Vincenzo Fraticelli, Attilio Guarini, Donato Mannina, Paola Ferrando, Paolo Corradini, Pellegrino Musto, Caterina Stelitano, Dario Marino, Andrea Camera, Marco Murineddu, Roberta Battistini, Giuseppe Caparrotti, Mauro Turrini, Luca Arcaini, Simone Santini, Manuela Cerqueti, Andres J. M. Ferreri, Nicola Cantore, Alessandro Inzoli, Giovanni Cardinale, Benedetto Ronci, Giorgio La Nasa, Stefano Massimi, Gianfranco Gaglione, Valentina Barbiero, Maurizio Martelli
Publikováno v:
Advances in Hematology, Vol 2022 (2022)
Subcutaneous (SC) rituximab may be beneficial in terms of convenience and tolerability, with potentially fewer and less severe administration-related reactions (ARRs) compared to the intravenous (IV) form. This report presents the results of a phase
Externí odkaz:
https://doaj.org/article/3480b587a0d945b293f445ff21680c7d
Autor:
Andrea Marino, Maddalena Calvo, Laura Trovato, Guido Scalia, Maria Gussio, Ugo Consoli, Manuela Ceccarelli, Giuseppe Nunnari, Bruno Cacopardo
Publikováno v:
Pathogens, Vol 12, Iss 2, p 304 (2023)
Hematological diseases, especially those causing severe neutropenia, represent the main factor in the development of invasive fungal infections (IFIs). Furthermore, COVID-19 has been considerably associated with IFIs due to immunological dysregulatio
Externí odkaz:
https://doaj.org/article/f13047d0da75498b90d40c3c2d443c72
Autor:
Massimo Gentile, Giorgina Specchia, Daniele Derudas, Monica Galli, Cirino Botta, Stefano Rocco, Concetta Conticello, Catello Califano, Nicola Giuliani, Silvia Mangiacavalli, Enrico Attingenti, Alessandra Lombardo, Marino Brunori, Elena Rossi, Elisabetta Antonioli, Roberto Ria, Renato Zambello, Nicola Di Renzo, Giuseppe Mele, Gianpaolo Marcacci, Pellegrino Musto, Silvana Capalbo, Nicola Cascavilla, Claudio Cerchione, Angelo Belotti, Clelia Criscuolo, Giuseppina Uccello, Paola Curci, Ernesto Vigna, Vincenzo Fraticelli, Donatella Vincelli, Angela Bonalumi, Agostina Siniscalchi, Raffaella Stocchi, Massimo Martino, Stelvio Ballanti, Dominella Gangemi, Alfredo Gagliardi, Barbara Gamberi, Alessandra Pompa, Anna Grazia Recchia, Giovanni Tripepi, Annalisa Pitino, Ferdinando Frigeri, Ugo Consoli, Sara Bringhen, Elena Zamagni, Francesca Patriarca, Valerio De Stefano, Francesco Di Raimondo, Salvatore Palmieri, Maria Teresa Petrucci, Massimo Offidani, Mario Boccadoro, Michele Cavo, Fortunato Morabito
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/b5ae14e00c9c4b92a6ae8d6e6f01ef6b
Publikováno v:
Clinical Management Issues, Vol 5, Iss 3S, Pp 13-17 (2015)
Here we describe the case of a 61-year-old woman who developed chronic myeloid leukaemia in chronic phase under treatment with antiaritmic-therapy (amiodarone) for Parossistic Sopraventricular Tachycardia (PSVT). Initially the patient started with im
Externí odkaz:
https://doaj.org/article/bf89ae7c7b35490dbb6f1bbfddb39ed3
Autor:
Antonio Pinto, Emanuele Guardalben, Marco Caltagirone, Chiara Piparo, Caterina Patti, Elsa Pennese, Sonya De Lorenzo, Vincenzo Pavone, Ugo Consoli, Francesco Piazza, Monia Capponi, Benedetta Puccini, Luca Baldini, Alessandro Pulsoni, Stefan Hohaus, Piero Maria Stefani, Simone Santini, Vittorio Ruggero Zilioli, Caterina Stelitano, Luca Arcaini, Giuseppe Gritti, Marco Ladetto, Pier Luigi Zinzani
Publikováno v:
Blood. 140:3638-3641
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d1277f105da905811e2e8ef643e23aa
https://doi.org/10.1182/blood-2022-165977
https://doi.org/10.1182/blood-2022-165977
Autor:
Antonella Bruzzese, Daniele Derudas, Monica Galli, Enrica Antonia Martino, Stefano Rocco, Concetta Conticello, Catello Califano, Nicola Giuliani, Silvia Mangiacavalli, Giuliana Farina, Alessandra Lombardo, Marino Brunori, Elena Rossi, Elisabetta Antonioli, Roberto Ria, Renato Zambello, Nicola Di Renzo, Giuseppe Mele, Gianpaolo Marcacci, Giuseppe Pietrantuono, Gaetano Palumbo, Nicola Cascavilla, Claudio Cerchione, Angelo Belotti, Clelia Criscuolo, Giuseppina Uccello, Paola Curci, Ernesto Vigna, Francesco Mendicino, Enrico Iaccino, Selena Mimmi, Cirino Botta, Donatella Vincelli, Nicola Sgherza, Angela Bonalumi, Luca Cupelli, Raffaella Stocchi, Massimo Martino, Stelvio Ballanti, Dominella Gangemi, Alfredo Gagliardi, Barbara Gamberi, Alessandra Pompa, Giovanni Tripepi, Ferdinando Frigeri, Ugo Consoli, Sara Bringhen, Elena Zamagni, Francesca Patriarca, Valerio De Stefano, Francesco Di Raimondo, Salvatore Palmieri, Maria Teresa Petrucci, Massimo Offidani, Pellegrino Musto, Mario Boccadoro, Michele Cavo, Antonino Neri, Fortunato Morabito, Massimo Gentile
Publikováno v:
Hematological Oncology. 40:704-715
The combination of elotuzumab, lenalidomide, and dexamethasone (EloRd) enhanced the clinical benefit over Rd with a manageable toxicity profile in the ELOQUENT-2 trial, leading to its approval in relapsed/refractory multiple myeloma (RRMM). The prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f542cee997418b008ccf5bad789db6c
https://doi.org/10.1002/hon.3031
https://doi.org/10.1002/hon.3031
Autor:
Francesco Reale, Paolo Silimbani, Mariasanta Napolitano, Vincenzo Accurso, Giuseppina Calvaruso, Donato Mannina, Aurelio Maggio, Giulia Arrigo, Alessandro Lucchesi, Sergio Siragusa, Ugo Consoli, Simona Raso, Giulio Giordano, Marco Santoro
Publikováno v:
Annals of Hematology. 100:653-659
The primary aim of this study was to describe the use of primary anti-infective prophylaxis (AP) in common clinical practice in patients affected by immune thrombocytopenia (ITP) and treated with RTX. Population studied consisted of patients affected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1494da4047ebe3535c597912af3384
https://doi.org/10.1007/s00277-021-04438-7
https://doi.org/10.1007/s00277-021-04438-7
Autor:
Roberto Palazzolo, Simona Raso, Nicola Serra, Sergio Siragusa, Ugo Consoli, Maria Rosa Lanza Cariccio, Melania Carlisi, Salvatrice Mancuso, Mariasanta Napolitano
Publikováno v:
Journal of Blood Medicine. 11:251-258
Purpose Insufficient knowledge of primary immune thrombocytopenia purpura (ITP) in the elderly, together with a lack of clinical trial data, has resulted in wide variation in treatments. Here, we present a study focused on clinical characteristics of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b407c066ad34f37fa7eb0bab69093fdd
https://doi.org/10.2147/jbm.s256620
https://doi.org/10.2147/jbm.s256620